MetaADEDB 2.0 @ LMMD
Hexachlorophene
(ACGUYXCXAPNIKK-UHFFFAOYSA-N)
Structure
SMILES
Clc1cc(Cl)c(c(c1O)Cc1c(O)c(Cl)cc(c1Cl)Cl)Cl
Type(s)
Approved; Withdrawn
ATC code(s)
D08AE01
Molecular Formula:
C13H6Cl6O2
Molecular Weight:
406.904
Log P:
6.6090
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
70-30-4
Synonym(s)
1.
Hexachlorophene
2.
Hexachlorophane
External Link(s)
MeSHD006582
PubChem Compound3598
BindingDB31712
ChEBI5693
CHEMBLCHEMBL496
DrugBankDB00756
DrugCentral1364
KEGGdr:D00859
cpd:C08039
Therapeutic Target DatabaseD0ZX2G
ZINC1530968
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1US FAERS
2HypersensitivityFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
3Therapeutic response unexpectedFAERS: 1US FAERS
4Application site reactionCanada Vigilance: 1Canada Vigilance
5Brain Diseases

View details

935180
958085
1137506
1687857
4212172
4700143
4738001
7462435
 		CTD
6Brain Edema1839603
4769005
10663390		CTD
7Dehydration4700143CTD
8Demyelinating Diseases7815895CTD
9DermatitisCanada Vigilance: 2Canada Vigilance
SIDER
10Diarrhea4700143CTD
11ErythemaCanada Vigilance: 24738001CTD
SIDER
Canada Vigilance
12Hypotension4700143CTD
13Infant, Premature, Diseases958085CTD
14Motor Skills Disorders10663390CTD
15Muscle Weakness4738001CTD
16Nausea4700143CTD
17Nerve Degeneration1117313CTD
18Optic Atrophy7377265CTD
19Peripheral Nervous System Diseases207073CTD
20Prenatal Exposure Delayed Effects25497112CTD
21PruritusCanada Vigilance: 2Canada Vigilance
22Rash erythematousCanada Vigilance: 6Canada Vigilance
23RednessSIDER
24Spinal Cord Diseases935180CTD
25UrticariaCanada Vigilance: 2Canada Vigilance
26Vision Disorders1117313CTD
27Vomiting4700143CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.